Abbreviated Name	Full Name
GSDME	gasdermin-E
PCD	programmed cell death
LPS	lipopolysaccharide
HMGB1	high-mobility group box 1
DMAPs	damage-associated molecular patterns
Bcl-2	B-cell lymphoma-2
TNFR1	type 1 TNF receptor
TRADD	TNF receptor-associated death domain
FADD	Fas-associated death domain
DISC	death-inducing signaling complex
MOMP	mitochondrial outer membrane permeabilization
APAF-1	apoptotic protease-activating factor-1
SLL	small lymphocytic lymphoma
Hsp90	heat shock protein 90
McL-1	myeloid cell Leukemia 1
GSDMA	gasdermin-A
GSDMB	gasdermin-B
GSDMC	gasdermin-C
PJVK	pejvakin
PS	phospholipids
PIPs	phosphatidylinositol phospholipids
IL-1β	interleukin-1β
IL-18	interleukin-18
ROS	reactive oxygen species
JNK	Jun N-terminal kinase
NF-kB	nuclear factor kappa-B
NK cells	natural killer cells
CAR-T	chimeric antigen receptor T-cell
TIME	tumor immune microenvironment
TAMs	tumor-associated macrophages
MDSCs	myeloid-derived suppressor cells
CRS	cytokine release syndrome
HDACI	histone deacetylase inhibitor
DAC	decitabine
PL	piperlongumine
VTPA	virus-spike tumor-activatable pyroptotic agent
GSH	glutathione
CCCP	carbonyl cyanide m-chlorophenizone
PDT	photodynamic therapy
phi-bf3	phenylalanine trifluoroborate
ADs	autoimmune diseases
PRF1	active perforin 1
GZMB	granzyme B
ATP	adenosine triphosphate
TNF	necrosis factor
RNAi	RNA interference
NDS	nanodelivery system
BNP	biomimetic nanoparticle
ICG	indocyanine green
NLRP3	nucleotide-binding domain and leucine-rich repeat protein-3